Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aparicio

Showing results (101-110 of 257) with videos related to

Pageof 26
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: the Spanish Germ-Cell Cancer Group experience (GG)J R Germà-Lluch, X Garcia del Muro, J M Tabernero, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 13, 2017
An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenibR Diaz-Beveridge, G Bruixola, D Lorente, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 30, 2019
Correction to: Recommendations for follow‑up of colorectal cancer survivorsR Vera, J Aparicio, F Carballo, et al.
Oncology|July 8, 2011
Brief report: phase II multicenter study of temozolomide in patients with cisplatin-resistant germ cell tumorsP Maroto, R Huddart, X Garcia del Muro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 15, 2019
Recommendations for follow-up of colorectal cancer survivorsR Vera, J Aparicio, F Carballo, et al.
Journal of Alzheimer'S Disease : JAD|May 31, 2021
Herpes Labialis, Chlamydophila pneumoniae, Helicobacter pylori, and Cytomegalovirus Infections and Risk of Dementia: The Framingham Heart StudyEduardo Marques Zilli, Adrienne O'Donnell, Joel Salinas, et al.
Semergen|November 12, 2013
[Use of glucose-lowering drugs in a primary care setting in Malaga during the years 2008-2012]J Mancera-Romero, A Hormigo-Pozo, J Fernández-Arquero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patientsI Maestu, M Pastor, J Gómez-Codina, et al.
Archivos De La Sociedad Espanola De Oftalmologia|June 12, 2002
[Scleral surgery of retinal detachment without drainage of subretinal fluid and no cryotherapy]M A Teijeiro Permuy, M P Vidal Fernández, M Suárez Leoz, et al.
JAMA Neurology|June 9, 2020
Assessment of Incidence and Risk Factors of Intracerebral Hemorrhage Among Participants in the Framingham Heart Study Between 1948 and 2016Vasileios-Arsenios Lioutas, Alexa S Beiser, Hugo J Aparicio, et al.
Pageof 26

Showing results (101-110 of 257) with videos related to

Sort By:
Pageof 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: the Spanish Germ-Cell Cancer Group experience (GG)J R Germà-Lluch, X Garcia del Muro, J M Tabernero, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 13, 2017
An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenibR Diaz-Beveridge, G Bruixola, D Lorente, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 30, 2019
Correction to: Recommendations for follow‑up of colorectal cancer survivorsR Vera, J Aparicio, F Carballo, et al.
Oncology|July 8, 2011
Brief report: phase II multicenter study of temozolomide in patients with cisplatin-resistant germ cell tumorsP Maroto, R Huddart, X Garcia del Muro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 15, 2019
Recommendations for follow-up of colorectal cancer survivorsR Vera, J Aparicio, F Carballo, et al.
Journal of Alzheimer'S Disease : JAD|May 31, 2021
Herpes Labialis, Chlamydophila pneumoniae, Helicobacter pylori, and Cytomegalovirus Infections and Risk of Dementia: The Framingham Heart StudyEduardo Marques Zilli, Adrienne O'Donnell, Joel Salinas, et al.
Semergen|November 12, 2013
[Use of glucose-lowering drugs in a primary care setting in Malaga during the years 2008-2012]J Mancera-Romero, A Hormigo-Pozo, J Fernández-Arquero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patientsI Maestu, M Pastor, J Gómez-Codina, et al.
Archivos De La Sociedad Espanola De Oftalmologia|June 12, 2002
[Scleral surgery of retinal detachment without drainage of subretinal fluid and no cryotherapy]M A Teijeiro Permuy, M P Vidal Fernández, M Suárez Leoz, et al.
JAMA Neurology|June 9, 2020
Assessment of Incidence and Risk Factors of Intracerebral Hemorrhage Among Participants in the Framingham Heart Study Between 1948 and 2016Vasileios-Arsenios Lioutas, Alexa S Beiser, Hugo J Aparicio, et al.
Pageof 26